Fauziah Mohd Jaafar
Inhibition of Orbivirus Replication by Fluvastatin and Identification of the Key Elements of the Mevalonate Pathway Involved
Mohd Jaafar, Fauziah; Monsion, Baptiste; Belhouchet, Mourad; Mertens, Peter P. C.; Attoui, Houssam
Authors
Baptiste Monsion
Mourad Belhouchet
Professor PETER MERTENS Peter.Mertens@nottingham.ac.uk
CHAIR IN VIROLOGY
Houssam Attoui
Abstract
Statin derivatives can inhibit the replication of a range of viruses, including hepatitis C virus (HCV, Hepacivirus), dengue virus (Flavivirus), African swine fever virus (Asfarviridae) and poliovirus (Picornaviridae). We assess the antiviral effect of fluvastatin in cells infected with orbiviruses (bluetongue virus (BTV) and Great Island virus (GIV)). The synthesis of orbivirus outer-capsid protein VP2 (detected by confocal immunofluorescence imaging) was used to assess levels of virus replication, showing a reduction in fluvastatin-treated cells. A reduction in virus titres of ~1.7 log (98%) in fluvastatin-treated cells was detected by a plaque assay. We have previously identified a fourth non-structural protein (NS4) of BTV and GIV, showing that it interacts with lipid droplets in infected cells. Fluvastatin, which inhibits 3-hydroxy 3-methyl glutaryl CoA reductase in the mevalonic acid pathway, disrupts these NS4 interactions. These findings highlight the role of the lipid pathways in orbivirus replication and suggest a greater role for the membrane-enveloped orbivirus particles than previously recognised. Chemical intermediates of the mevalonic acid pathway were used to assess their potential to rescue orbivirus replication. Pre-treatment of IFNAR(−/−) mice with fluvastatin promoted their survival upon challenge with live BTV, although only limited protection was observed.
Citation
Mohd Jaafar, F., Monsion, B., Belhouchet, M., Mertens, P. P. C., & Attoui, H. (2021). Inhibition of Orbivirus Replication by Fluvastatin and Identification of the Key Elements of the Mevalonate Pathway Involved. Viruses, 13(8), Article 1437. https://doi.org/10.3390/v13081437
Journal Article Type | Article |
---|---|
Acceptance Date | Jul 20, 2021 |
Online Publication Date | Jul 23, 2021 |
Publication Date | Aug 1, 2021 |
Deposit Date | Jul 27, 2021 |
Publicly Available Date | Jul 27, 2021 |
Journal | Viruses |
Electronic ISSN | 1999-4915 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Issue | 8 |
Article Number | 1437 |
DOI | https://doi.org/10.3390/v13081437 |
Keywords | Virology; Infectious Diseases |
Public URL | https://nottingham-repository.worktribe.com/output/5841656 |
Publisher URL | https://www.mdpi.com/1999-4915/13/8/1437 |
Files
Inhibition of Orbivirus Replication by Fluvastatin and Identification of the Key Elements of the Mevalonate Pathway Involved
(3.6 Mb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Orbivirus NS4 Proteins Play Multiple Roles to Dampen Cellular Responses
(2023)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search